Clinical Trial Update: Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients

View source ↗

Summary

Non-interventional European study evaluating trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Trabectedin + PLD

Snippet

Sponsor: PharmaMar | Conditions: Relapsed Ovarian Cancer | Status: COMPLETED | Results posted: 2021-10-29